Influenza

Infectious Disease Clinics of North America

Volumn 14, Issue 1, 2000, Pages 141-166

  Stamboulian, Daniel ^a,b   Bonvehí, Pablo E ^b,c   Nacinovich, Francisco M ^b   Cox, Nancy ^d  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Fundación del Centro De Estudios Infectológicos   (Argentina)

^c CEMIC   (Argentina)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; DNA VACCINE; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; LIVE VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; OSELTAMIVIR; PRASTERONE; QS 21; RIMANTADINE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

ANTIVIRAL ACTIVITY; BRAIN DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONVULSION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; EPIDEMIC; ERYTHEMA; FEVER; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEALTH CARE PLANNING; HEART DISEASE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFLUENZA; INJECTION PAIN; LABORATORY DIAGNOSIS; MALAISE; MYALGIA; MYOSITIS; NEUROTOXICITY; OTITIS MEDIA; PNEUMONIA; RESPIRATORY TRACT DISEASE; REVIEW; REYE SYNDROME;

EID: 0034017970     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70222-1     Document Type: Article

References (97)

1. G.L. Ada G.A. Tannock A.W. Hampson Options for the control of influenza III. Cairns, North Queensland, Australia (4–9 May 1996) Vaccine 15 1997 245
2. K. Anderson R. Teske E. Dini Improving Influenza Vaccination Coverage in the Medicare Population Hannounn C. Kendal A.P. Klenk H.D. Options for the Control of Influenza II 1993 Elsevier Science Publishers BV Amsterdam 109
3. F.Y. Aoki Amantadine and rimantadine Nicholson K.G. Webster R.G. Hay A.J. Textbook of Influenza 1998 Blackwell Science Ltd Oxford 457
4. Arduino RC, Martin T, Bonvehí P, et al: Safety of inactivated subunit influenza virus vaccines (ISIVVs) combined with MF59 adjuvant emulsion [abstract H-109]. In Programs and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Sept 15–18, 1996
5. J. Aschan O. Ringdien P. Ljungman Influenza B in transplant patients Scand J Infect Dis 21 1989 349
6. M. Aymard N.J. Cox G. Dubois Recommendations of the 7th European Meeting of Influenza and Its Prevention Eur J Epidemiol 10 1994 525
7. D. Bainton G.R. Jones D. Hole Influenza and ischemic heart disease: A possible trigger for acute myocardial infarction? Int J Epidemiol 7 1978 231
8. W.H. Baker J.P. Mullooly Pneumonia and influenza deaths during epidemics Arch Intern Med 142 1989 85
9. W.H. Barker Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970–78 Am J Public Health 76 1996 761
10. E.D. Belay J.S. Bresee R.C. Holman Reye's syndrome in the United States from 1981 through 1997 N Engl J Med 340 1999 1377
11. R.B. Belshe The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children N Engl J Med 20 1998 1405
12. R.F. Betts Influenza virus Mandell G.L. Dolin R. Bennett J.E. Principles and Practice of Infectious Diseases ed 4 1995 Churchill Livingstone New York 1546
13. P. Bisel Y. Kawoaka New approaches to vaccination Nicholson K.G. Webster R.G. Hay A.J. Textbook of Influenza 1998 Blackwell Science Ltd Oxford 422
14. S.S. Bondarenko F.A. Tumanov The effect of influenza and parainfluenza on the course of ischemic heart disease Ter Arkh 64 1992 81
15. Bonvehí PE, Nacinovich FM, Rüttimann RW, et al: Effectiveness of influenza vaccine in elderly people living in the community in Argentina [abstract H-137]. In Proceedings and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Sept 28–Oct 1, 1997
16. J.T. Brocklebank S.D. Court J. McQuillin Influenza A infections in children Lancet 2 1972 497
17. D.P. Calfee F.G. Hayden New approaches to influenza chemotherapy. Neuraminidase inhibitors Drugs 56 1998 537
18. D.P. Calfee A.W. Peng L.M. Cass Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection Antimicrob Agents Chemother 43 1999 1616
19. F. Carrat A. Tachet C. Rouzioux Evaluation of clinical case definitions of influenza: Detailed investigation of patients during the 1995–1996 epidemic in France Clin Infect Dis 28 1999 283
20. S.D. Collins Age and sex incidence of influenza and pneumococcal morbidity and mortality in the epidemic of 1928–29 with comparative data for the epidemic of 1918–19 Public Health Rep 46 1931 1909
21. N.J. Cox C.A. Bender The molecular epidemiology of influenza viruses Seminars in Virology 6 1995 359
22. N.J. Cox K. Fukuda Influenza Infect Dis Clin North Am 12 1998 27
23. N.J. Cox K. Subbarao Influenza. In Lancet Seminars Lancet 354 1999 1277 1282
24. F.M. Davenport A.V. Hennessy T. Francis Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus J Exp Med 98 1953 641
25. R.C. Dykes J.D. Cherry C.E. Nolan A clinical, epidemiologic, serologic, and virologic study of influenza C virus infection Arch Intern Med 140 1980 1295
26. F.A. Ennis Q. Yi-Hua C.G. Schild Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines J Gen Virol 58 1982 273
27. D.S. Fedson C. Hannoun J. Leese Influenza vaccination in 18 developed countries 1980–1992 Vaccine 13 1995 623
28. D.S. Fedson Y. Hirota H.K. Shin Influenza vaccination in 22 developed countries: An update to 1995 Vaccine 15 1997 1506
29. D.A. Foster A. Talsma Furumoto Dawson A. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly Am J Epidemiol 136 1992 296
30. J.P. Fox C.E. Hall M.K. Cooney Influenza virus infections in Seattle families, 1975–79. I. Study design, methods and the occurrence of infections by time and age Am J Epidemiol 116 1982 212
31. W.H. Frost The epidemiology of influenza JAMA 73 1919 313
32. J.D. Fuller D.E. Craven K.A. Steger Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: Impact on plasma levels of HIV type 1 RNA and determinants of antibody response Clin Infect Dis 28 1999 541
33. P. Gardner T. Eickhoff Immunization in Adults in the 1990s Remington J.S. Swartz M.N. Current Clinical Topics in Infectious Diseases 1995 Blackwell Science Ltd Oxford 271
34. W.P. Glezen R.B. Couch Interpandemic influenza in the Houston area, 1974–76 N Engl J Med 298 1978 587
35. W.P. Glezen Emerging infections: Pandemic influenza Epidemiol Rev 18 1996 64
36. W.P. Glezen Serious morbidity and mortality associated with influenza epidemics Epidemiol Rev 4 1982 25
37. T.M. Govaert G.J. Dinant K. Aretz Adverse reactions to influenza vaccine in elderly people: Randomized double blind placebo controlled trial BMJ 307 1993 988
38. P.A. Gross The efficacy of influenza vaccine in elderly persons Ann Intern Med 123 1995 518
39. A. Hampson N.J. Cox Global Surveillance for Pandemic Influenza: Are We Prepared? Brown L.E. Hampson A.W. Webster R.G. Options for the Control of Influenza III 1996 Elsevier Amsterdam 50
40. Hayden FG, Lobo M, Treanor JJ, et al: Efficacy and tolerability of oral GS4104 for early treatment of experimental influenza in humans [abstract LB-26.] Presented at the 37th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Sept 28–Oct 1, 1997
41. F.G. Hayden A.D. Osterhaus J.J. Treanor Efficacy and safety of the neuraminidase inhibitor Zanamivir in the treatment of influenza virus infections N Engl J Med 337 1997 874
42. N.L. Hordvik P. Könog B. Hamory Effects of acute viral respiratory tract infections in patients with cystic fibrosis Pediatr Pulmonol 7 1989 217
43. T.W. Hoskins J.R. Davies A.J. Smith Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital Lancet 1 1979 33
44. Jordon W.S. Jr The mechanism of spread of Asian influenza Am Rev Respir Dis 83 1961 29
45. J. Karajalinen M.S. Nieminen J. Heikkila Influenza A1 myocarditis in conscripts Acta Medida Scandinavica 207 1980 27
46. 1) influenza in young men N Engl J Med 307 1982 1042
47. A.A. Kerr M.A. Downham J. Mcquillan Gastric flu influenza B causing abdominal symptoms in children Lancet 1 1975 291
48. E.D. Kilbourne N.H. Arden Inactivated influenza virus Plotkin S.A. Mortimer E.A. Vaccines 1998 WB Saunders Philadelphia 531
49. W.G. Laver N. Bischofberger R.G. Webster Disarming flu viruses Scientific American 280 1999 78
50. J. Lederberg R.E. Shope Oaks S.C. Jr Emerging Infections—Microbial Threats to Health in the United States 1993 National Academy Press Washington, DC 18 19 86–87
51. J. Leese S.E. Tamblyn Pandemic Planning Nicholson K.G. Webster R.G. Hay A.J. Textbook of Influenza 1998 Blackwell Science Ltd Oxford 551
52. P. Ljungmann J. Anderson J. Aschan Influenza A in immunocompromised patients Clin Infect Dis 17 1993 244
53. K.J. Lui A.P. Kendal Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985 Am J Public Health 77 1987 712
54. K.L. Margolies K.L. Nichol R.E. Poland Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial JAMA 264 1990 1139
55. J.A. McCullers S. Facchini P.J. Chesney Influenza B virus encephalitis Clin Infect Dis 28 1999 898
56. A.S. Monto D.M. Fleming deGroot R. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections J Infect Dis 180 1999 254
57. A.S. Monto D.A. Iacuzio J.R. LaMontagne Pandemic influenza—confronting a reemergent threat J Infect Dis 176 1997 S1
58. A.S. Monto F. Koumehr The Tecumseh study of respiratory illness. IX. Occurrence of influenza in the community, 1966–1971 Am J Epidemiol 102 1975 553
59. A.S. Monto D.P. Robinson M.L. Herlocher Zanamivir in the prevention of influenza among healthy adults JAMA 282 1999 31
60. H. Moriuchi N. Katsushima H. Nishimura Community-acquired influenza C virus infection in children J Pediatr 118 1991 235
61. M.R. Moser T.R. Bender H.S. Margolis An outbreak of influenza aboard a commercial airliner Am J Epidemiol 110 1979 1
62. S.E. Moss R. Klein B.E. Klein Cause-specific mortality in a population-based study of diabetes Am J Public Health 81 1991 1158
63. K.M. Neuzil G.W. Reed Mitchel E.F. Jr Influenza-associated morbidity and mortality in young and middle-aged women JAMA 281 1999 901
64. K.M. Neuzil G.W. Reed E.F. Mitchell Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women Am J Epidemiol 148 1998 1094
65. K.L. Nichol L. Baken A. Nelson Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease Ann Intern Med 130 1999 397
66. K.L. Nichol The effectiveness of vaccination against influenza in healthy, working adults N Engl J Med 333 1995 889
67. K.L. Nichol K.L. Margolies J. Wuorenma The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community N Engl J Med 331 1994 778
68. K.L. Nichol Efficacy/Clinical Effectiveness of Inactivated Influenza Virus Vaccines in Adults Nicholson K.G. Webster R.G. Hay A.J. Textbook of Influenza 1998 Blackwell Science Ltd Oxford 358
69. K.L. Nichol Preventing influenza: The physician's role Semin Respir Infect 7 1992 71
70. K.G. Nicholson R.G. Webster A.J. Hay Textbook of Influenza 1998 Blackwell Science Ltd Oxford 219
71. K.G. Nicholson Clinical features of influenza Semin Respir Infect 7 1992 26
72. S.E. Ohmit A.S. Monto Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons Int J Epidemiol 24 1995 1240
73. P.A. Patriarca N.J. Cox Influenza pandemic preparedness plan for the United States J Infect Dis 176 1997 S4
74. Prevention and control of influenza Recommendations of the Advisory Committee on Immunizations Practices (ACIP) MMWR Morb Mortal Wkly Rep 48 RR-04 1999 1
75. D.A. Price R.J. Postlethwaite M. Longson Influenza virus A2 infections presenting with febrile convulsions and gastrointestinal symptoms in young children Clin Pediatr (Phila) 15 1976 361
76. N. Rabella P. Rodriguez R. Labeaga Conventional respiratory viruses recovered from immunocompromised patients: Clinical considerations Clin Infect Dis 28 1999 1043
77. 2) strains isolated in Latin American and Caribbean countries since 1991 [P17.9]. In Programs and Abstracts of the International Conference on Emerging Infectious Diseases. Atlanta, Georgia, 1997
78. P.S. Reichelderfer A.P. Kendal K.F. Shotgridge Influenza surveillance in the Pacific Basin—seasonality of virus occurrence: A preliminary report Current Topics in Medical Virology 1988 412
79. A.H. Reid T.G. Fanning J.V. Hultin Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene Proc Natl Acad Sci U S A 96 1999 1651
80. Rüttimann R, Izurieta HS, Arduino RC, et al: Effect of annual influenza vaccine on the immunologic response in the elderly [abstract P13]. In Programs and Abstracts of the First Annual Conference on Vaccine Research. Washington, DC, 1998, p 43
81. Savy V, Baumeister E, Campos A, et al: Cepas circulantes de influenza y su relación con las cepas vacunales [abstract III 375]. In I Congreso Internacional de Infectología y Microbiología Clínica (SADI-SADEBAC). Buenos Aires, June, 1997
82. K.F. Shortridge The next pandemic influenza virus? Lancet 346 1995 1210
83. L. Simonsen M.J. Clarke G.D. Williamson The impact of influenza epidemics on mortality: Introducing a severity index Am J Public Health 87 1997 1944
84. Stamboulian D, Bonvehí PE, Nacinovich FM, et al: Influenza immunization among elderly people in Argentina [abstract 54.030]. In 8th International Congress on Infectious Diseases. Boston, May 15–18, 1998, p 168
85. N. Sugaya K. Nerome M. Ishida Impact of influenza virus infection as a cause of pediatric hospitalization J Infect Dis 165 1992 373
86. J.K. Taubenberger A.H. Reid A.E. Krafft Initial genetic characterization of the 1918 “Spanish” influenza virus Science 275 1997 1793
87. R.L. Tominack F.G. Hayden Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections Infect Dis Clin North Am 1 1987 459
88. 1) virus [abstract]. In European Respiratory Society Annual Congress, Geneva, 1998
89. J.J. Treanor H.R. Mattison G. Dumyati Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly Ann Intern Med 117 1992 625
90. R.G. Webster W.J. Bean O.T. Gorman Evolution and ecology of influenza A viruses Microbiol Rev 56 1992 152
91. R.G. Webster Y. Kawaoka Influenza—an emerging and re-emerging disease Seminars in Virology 5 1994 103
92. R.G. Webster DNA Vaccination: A Potential Future Strategy Nicholson K.G. Webster R.G. Hay A.J. Textbook of Influenza 1998 Blackwell Science Ltd Oxford 410
93. E. Whimbey L.S. Elting R.B. Couch Influenza A virus infections among hospitalized adult bone marrow transplant recipients Bone Marrow Transplant 13 1994 437
94. D.C. Wiley I.A. Wilkson J.J. Skehel Structural identification of the antibody-binding sites of Hong Kong influenza hemagglutinin and their involvement in antigenic variation Nature 289 1981 373
95. I.A. Wilkson N.J. Cox Structural basis of immune recognition of influenza virus hemagglutinin Annu Rev Immunol 8 1990 737
96. H.M. Yousuf J. Englund R. Couch Influenza among hospitalized adults with leukemia Clin Infect Dis 24 1997 1095
97. T. Ziegler N.J. Cox Influenza Viruses Murray P.R. Manual of Clinical Microbiology ed 7 1999 ASM Press Washington, DC 928